WASHINGTON – GenBioPro, which sells the generic version of the abortion pill mifepristone, hired its own team of lobbyists for the first time this summer, according to new federal disclosures.
GenBioPro has hired two lobbyists from the firm Emergent Strategies to advocate on “Issues related to medication abortion … abortion access [and] FDA Approval of Mifepristone,” its filing states. Emergent officially registered to represent GenBioPro on July 11.
GenBioPro is one of just two companies in the United States that makes these pills, which terminate a pregnancy by blocking the pregnancy hormone progesterone.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
